File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/0008-5472.CAN-12-1269
- Scopus: eid_2-s2.0-84869228632
- PMID: 22991305
- WOS: WOS:000311141300037
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma
Title | Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma |
---|---|
Authors | |
Issue Date | 2012 |
Publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ |
Citation | Cancer Research, 2012, v. 72 n. 22, p. 6024-6035 How to Cite? |
Abstract | Esophageal squamous cell carcinoma (ESCC), the major histologic subtype of esophageal cancer, is a devastating disease characterized by distinctly high incidences and mortality rates. However, there remains limited understanding of molecular events leading to development and progression of the disease, which are of paramount importance to defining biomarkers for diagnosis, prognosis, and personalized treatment. By high-throughout transcriptome sequence profiling of nontumor and ESCC clinical samples, we identified a subset of significantly differentially expressed genes involved in integrin signaling. The Rab25 gene implicated in endocytic recycling of integrins was the only gene in this group significantly downregulated, and its downregulation was confirmed as a frequent event in a second larger cohort of ESCC tumor specimens by quantitative real-time PCR and immunohistochemical analyses. Reduced expression of Rab25 correlated with decreased overall survival and was also documented in ESCC cell lines compared with pooled normal tissues. Demethylation treatment and bisulfite genomic sequencing analyses revealed that downregulation of Rab25 expression in both ESCC cell lines and clinical samples was associated with promoter hypermethylation. Functional studies using lentiviral-based overexpression and suppression systems lent direct support of Rab25 to function as an important tumor suppressor with both anti-invasive and -angiogenic abilities, through a deregulated FAK–Raf–MEK1/2–ERK signaling pathway. Further characterization of Rab25 may provide a prognostic biomarker for ESCC outcome prediction and a novel therapeutic target in ESCC treatment. |
Persistent Identifier | http://hdl.handle.net/10722/184488 |
ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.468 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tong, M | - |
dc.contributor.author | Chan, KW | - |
dc.contributor.author | Bao, JYJ | - |
dc.contributor.author | Wong, KY | - |
dc.contributor.author | Chen, J | - |
dc.contributor.author | Kwan, PS | - |
dc.contributor.author | Tang, KH | - |
dc.contributor.author | Fu, L | - |
dc.contributor.author | Qin, YR | - |
dc.contributor.author | Lok, S | - |
dc.contributor.author | Guan, X | - |
dc.contributor.author | Ma, S | - |
dc.date.accessioned | 2013-07-15T09:50:25Z | - |
dc.date.available | 2013-07-15T09:50:25Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Cancer Research, 2012, v. 72 n. 22, p. 6024-6035 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | http://hdl.handle.net/10722/184488 | - |
dc.description.abstract | Esophageal squamous cell carcinoma (ESCC), the major histologic subtype of esophageal cancer, is a devastating disease characterized by distinctly high incidences and mortality rates. However, there remains limited understanding of molecular events leading to development and progression of the disease, which are of paramount importance to defining biomarkers for diagnosis, prognosis, and personalized treatment. By high-throughout transcriptome sequence profiling of nontumor and ESCC clinical samples, we identified a subset of significantly differentially expressed genes involved in integrin signaling. The Rab25 gene implicated in endocytic recycling of integrins was the only gene in this group significantly downregulated, and its downregulation was confirmed as a frequent event in a second larger cohort of ESCC tumor specimens by quantitative real-time PCR and immunohistochemical analyses. Reduced expression of Rab25 correlated with decreased overall survival and was also documented in ESCC cell lines compared with pooled normal tissues. Demethylation treatment and bisulfite genomic sequencing analyses revealed that downregulation of Rab25 expression in both ESCC cell lines and clinical samples was associated with promoter hypermethylation. Functional studies using lentiviral-based overexpression and suppression systems lent direct support of Rab25 to function as an important tumor suppressor with both anti-invasive and -angiogenic abilities, through a deregulated FAK–Raf–MEK1/2–ERK signaling pathway. Further characterization of Rab25 may provide a prognostic biomarker for ESCC outcome prediction and a novel therapeutic target in ESCC treatment. | - |
dc.language | eng | - |
dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | - |
dc.relation.ispartof | Cancer Research | - |
dc.title | Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma | - |
dc.type | Article | - |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0008-5472&volume=72&spage=6024&epage=6035&date=2012&atitle=Rab25+is+a+tumor+suppressor+gene+with+anti-angiogenic+and+anti-invasive+activities+in+esophageal+squamous+cell+carcinoma | en_US |
dc.identifier.email | Tong, M: caroltm@hku.hk | - |
dc.identifier.email | Chan, KW: hrmtckw@hku.hk | - |
dc.identifier.email | Bao, JYJ: baoyj@hku.hk | - |
dc.identifier.email | Wong, KY: kywonga@hkucc.hku.hk | - |
dc.identifier.email | Kwan, PS: kwanps@hku.hk | - |
dc.identifier.email | Fu, L: gracefu@graduate.hku.hk | - |
dc.identifier.email | Lok, S: silok@genome.hku.hk | - |
dc.identifier.email | Guan, X: xyguan@hkucc.hku.hk | - |
dc.identifier.email | Ma, S: stefma@hku.hk | - |
dc.identifier.authority | Tong, M=rp02568 | - |
dc.identifier.authority | Chan, KW=rp00330 | - |
dc.identifier.authority | Fu, L=rp01435 | - |
dc.identifier.authority | Lok, S=rp00271 | - |
dc.identifier.authority | Guan, X=rp00454 | - |
dc.identifier.authority | Ma, S=rp00506 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1158/0008-5472.CAN-12-1269 | - |
dc.identifier.pmid | 22991305 | - |
dc.identifier.scopus | eid_2-s2.0-84869228632 | - |
dc.identifier.hkuros | 215084 | - |
dc.identifier.volume | 72 | - |
dc.identifier.issue | 22 | - |
dc.identifier.spage | 6024 | - |
dc.identifier.epage | 6035 | - |
dc.identifier.isi | WOS:000311141300037 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0008-5472 | - |